Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Center for Biologics Evaluation and Research (CBER)

Center for Biologics Evaluation and Research (CBER)

                        CBER Offices & Divisions
          CBER Vision & Mission
          CBER Reports
          CBER Ombudsman
          CBER Product Jurisdiction
          Jobs at the Center for Biologics Evaluation and Research (CBER) Home
          About FDA
          FDA Organization
          Center for Biologics Evaluation and Research (CBER)
          Staff Fellow - Researcher-ReviewerCenter for Biologics Evaluation and Research (CBER) Staff Fellow - Researcher-Reviewer
  
  	
    Share
    Post
    Linkedin

    Email
    Print**OFFICE OF THERAPEUTIC PRODUCTS (OTP)
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER)
FOOD AND DRUG ADMINISTRATION (FDA)
DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)**

The Office of Gene Therapy (OGT) and Office of Cellular Therapy and Human Tissue (OCTHT) within the Center for Biologics Evaluation and Research (CBER), Office of Therapeutic Products (OTP) at FDA are recruiting to fill multiple Staff Fellow positions to serve as a **researcher-reviewer** in the Gene Transfer and Immunogenicity Branch (GTIB), the Tumor Vaccines and Biotechnology Branch (TVBB), and the Cellular and Tissue Therapy Branch (CTTB) within OGT and OCTHT.

OGT and OCTHT protect and enhance public health by assuring that cell and gene-based therapeutic products (including cancer vaccines) and tissue engineered products are safe and effective.

**RESPONSIBILITIES:** The successful candidate will perform the following major duties:

Conducting laboratory research related to cell therapy or gene therapy, including developing novel strategies to assess safety of these products and research on characterizing and manufacturing these products. The successful candidate will join one of the research labs in OGT and OCTHT based on the candidate’s qualifications and area of research. Currently, OGT and OCTHT labs perform research in the following areas:
	Gene therapy
		Genome editing
		AAV vectors
		Immunology
		Hematopoietic stem cells
		CAR-T cells
		CAR-NK cells
		Next-generation sequencing
		Cell therapy (adult cells and stem cells)
		Cell-based tissue engineered products
		Biomaterials
	Performing regulatory review of cell and gene therapy product applications submitted to the FDA.**BASIC QUALIFICATIONS:**Applicants will be required to meet the specific qualification requirements of the applicable occupational series below.

General Natural Resources Management and Biological Sciences (RG-0401): Degree in Biological sciences, agriculture, natural resource management, chemistry, or related disciplines appropriate to the position, – OR – Combination of education and experience in courses equivalent to a major, plus appropriate experience or additional education.

**ADDITIONAL QUALIFICATIONS:** Ph.D. in Biomedical Science or equivalent doctoral degree (M.D., D.V.M., or Sc.D., etc.) is required. Candidates must also have strong collaborative skills, and excellent written and oral communication skills.

**PREFERRED SPECIALIZED EXPERIENCE:**For positions in OGT labs, candidates with prior research experience in immunology, virology, gene therapy, or genome editing are desirable. For positions in OCTHT labs, experience in biomaterials and/or bioreactors, cell manufacturing, and -omics analysis (metabolomics and proteomics), immunology, cell therapy, or next-generation sequencing is desirable. *To learn more about current research programs, please visit the Tissue & Advanced Therapies Research | FDA.*

**FOREIGN EDUCATION:**If you are using education completed in foreign colleges or universities to meet the qualification requirements, you must show that the education credentials have been evaluated by a private organization that specializes in interpretation of foreign education programs and such education has been deemed equivalent to that gained in an accredited U.S. education program; or full credit has been given for the courses at a U.S. accredited college or university. *For further information, visit the**U.S. Department of Education website for Foreign Education Evaluation**.*

**SALARY:** Salary is commensurate with education and experience, including an excellent benefits package.

**LOCATION:** FDA White Oak Campus in Silver Spring, MD

**CONDITIONS OF EMPLOYMENT:** This position will be filled through the Service Fellowship program, with an initial appointment period followed by opportunities for renewal. **Applications will be accepted from all groups of qualified candidates, including U.S. citizens or non-U.S. Citizens holding valid immigration status and work authorization at the FDA**. No previous Federal experience is required. Appointment does not confer any entitlement to a position in the competitive service, and during the initial appointment there is no entitlement to Merit Systems Protection Board (MSPB) appeals rights.

One-year probationary period may be required.
	Official Transcripts for undergraduate and graduate degrees required
	Background and/or Security investigation required.
	If applicant is an U.S. Citizen, males born on, or after, December 31st, 1959 must be registered with the Selective Service System or have an approved exemption. Visit www.SSS.gov for more info.
	Prohibited financial interest restrictions may apply. For additional information on the prohibited financial interests, please visit the FDA Ethics and Integrity Office website at FDA Ethics and Integrity Office.**HOW TO APPLY:**Submit electronic resume or curriculum vitae, a cover letter in which you describe your qualifications and career goals and name and contact information for two references (non-government employees) to Rebecca.Escobar@fda.hhs.gov. Applications and all supporting documentation will be accepted through April 30, 2024 and will be reviewed on a rolling basis. Please reference Job Code: **OTP-24-02-CJP**.

**ADDITIONAL INFORMATION:**For additional information on CBER Careers, please visit:

*Jobs at the Center for Biologics Evaluation and Research (CBER) | FDA*
	*Scientific Careers at the FDA**HHS/FDA is an equal opportunity and affirmative action employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or protected veteran status*

                                                                                  Content current as of:
      01/25/2024Center for Biologics Evaluation and Research (CBER)

          
                        CBER Offices & Divisions
          CBER Vision & Mission
          CBER Reports
          CBER Ombudsman
          CBER Product Jurisdiction
          Jobs at CBER
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop